Business
Bloomberg reports that increased competition with cheaper generics may push Teva to make a major acquisition soon. Perrigo Company (NYSE:PRGO; TASE:PRGO) may be a...
Hi, what are you looking for?
Bloomberg reports that increased competition with cheaper generics may push Teva to make a major acquisition soon. Perrigo Company (NYSE:PRGO; TASE:PRGO) may be a...
– Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has announced : the Food and Drug Administration (FDA) approval and the launch of the...
– The QNASL nasal spray, approved in 2012 for adults, treats nasal symptoms of allergic rhinitis, including hay fever, in children. Teva Pharmaceutical Industries...
– Relations between Teva and Biotec have deteriorated into a legal dispute and an entanglement with the Russian authorities. – After years of...
– Teva has lost its 180 days exclusivity for the generic version of Pfizer’s arthritis and chronic pain treatment. – The US Supreme...
– “We are upgrading our recommendation for Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) from “Market perform” to “Market outperform” with a target...
– Novartis will invest $10 million in BioLineRX for a 12.8% stake. They will select three projects for joint development. – Drug development...
– Pfizer will pay $295 million for the growth hormone treatment and up to $275 million in milestone payments, and royalties. Pfizer Inc. (NYSE:...
– Generic competition for Copaxone and foreign currency volatility will hit Teva’s sales. – When Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA)...
– The decision gives Teva more time to transfer patients to its better patent protected double dosage Copaxone. – Teva Pharmaceutical Industries Ltd. (NYSE:...